Nkarta, Inc. Contracts & Agreements
47 Contracts & Agreements
- Business Finance (10 contracts)
- Business Operations (6)
- Human Resources (18)
- Intellectual Property (1)
- Real Estate (11)
- Uncategorized (1)
- Employment Offer between Nkarta, Inc. and Nadir Mahmood (Filed With SEC on November 7, 2024)
- Amendment No. 3 to the Research Collaboration Agreement, dated April 3, 2024, by and between Nkarta, Inc. and CRISPR Therapeutics AG (Filed With SEC on August 13, 2024)
- Amendment No. 4 to the Research Collaboration Agreement, dated May 2, 2024, by and between Nkarta, Inc. and CRISPR Therapeutics AG (Filed With SEC on August 13, 2024)
- Underwriting Agreement, dated March 25, 2024, among Nkarta, Inc., Leerink Partners LLC and Cowen and Company, LLC, as representatives of the several underwriters named therein (Filed With SEC on March 28, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on March 28, 2024)
- Description of Capital Stock (Filed With SEC on March 21, 2024)
- Employment Offer Letter between Nkarta, Inc. and David Shook (Filed With SEC on March 21, 2024)
- Employment Offer Letter between Nkarta, Inc. and Alyssa Levin (Filed With SEC on August 10, 2023)
- Fourth Amendment to Lease, dated June 14, 2023, by and between HCP BTC, LLC and Nkarta, Inc (Filed With SEC on August 10, 2023)
- Amendment No. 2 to the Research Collaboration Agreement, dated March 8, 2023, by and between Nkarta, Inc. and CRISPR Therapeutics AG (Filed With SEC on May 11, 2023)
- Nkarta, Inc. Non-Employee Director Compensation Policy, as amended on March 22, 2023 (Filed With SEC on May 11, 2023)
- Third Amendment to Lease, dated April 25, 2023, by and between HCP BTC, LLC and Nkarta, Inc (Filed With SEC on May 11, 2023)
- Second Amendment to Lease, dated August 11, 2022, by and between HCP BTC, LLC and Nkarta, Inc (Filed With SEC on August 11, 2022)
- Fifth Amendment to Lease, dated August 11, 2022, by and between HCP Life Science REIT, Inc. and Nkarta, Inc (Filed With SEC on August 11, 2022)
- Amendment No. 1 to the Research Collaboration Agreement, dated May 4, 2022, by and between Nkarta, Inc. and CRISPR Therapeutics AG (Filed With SEC on May 12, 2022)
- Underwriting Agreement, dated April 25, 2022, among Nkarta, Inc., Cowen and Company, LLC, SVB Securities LLC and Evercore Group L.L.C., as representatives of the several... (Filed With SEC on April 28, 2022)
- Nkarta, Inc. Non-Employee Director Compensation Policy, as amended on March 16, 2022 (Filed With SEC on March 17, 2022)
- First Amendment to Lease, dated November 5, 2021, by and between HCP BTC, LLC and Nkarta, Inc (Filed With SEC on November 10, 2021)
- Fourth Amendment to Lease, dated October 19, 2021, by and between HCP Life Science REIT, Inc. and Nkarta, Inc (Filed With SEC on October 22, 2021)
- Research Collaboration Agreement, dated May 5, 2021, by and between Nkarta, Inc. and CRISPR Therapeutics AG (Filed With SEC on August 12, 2021)
- Lease, dated July 9, 2021, by and between HCP BTC, LLC and Nkarta, Inc (Filed With SEC on July 14, 2021)
- Nkarta, Inc. Non-Employee Director Compensation Policy, as amended March 24, 2021 (Filed With SEC on May 13, 2021)
- Employment Offer Letter between the Registrant and Dr. Nadir Mahmood (Filed With SEC on May 13, 2021)
- First Amendment to Employment Offer Letter between the Registrant and Dr. Nadir Mahmood (Filed With SEC on May 13, 2021)
- Employment Offer Letter between the Registrant and Dr. Alicia Hager (Filed With SEC on May 13, 2021)
- Description of Capital Stock (Filed With SEC on March 25, 2021)
- Third Amendment to Lease Agreement, dated January 14, 2021, by and between the Registrant and HCP Life Science REIT, Inc (Filed With SEC on March 25, 2021)
- Form of Severance Agreement (Filed With SEC on January 13, 2021)
- Nkarta, Inc. Non-Employee Director Compensation Policy (Filed With SEC on November 12, 2020)
- Separation and Release Agreement between Nkarta. Inc. and Matthew Plunkett, dated October 2, 2020 (Filed With SEC on October 5, 2020)
- Form of Director Option Agreement (Filed With SEC on August 20, 2020)
- Form of non-qualified Stock Option (Filed With SEC on August 20, 2020)
- Form of Underwriting Agreement (Filed With SEC on July 2, 2020)
- Form of Common Stock Certificate of the Registrant (Filed With SEC on July 2, 2020)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on July 2, 2020)
- 2020 Performance Incentive Plan (Filed With SEC on July 2, 2020)
- 2020 Employee Stock Purchase Plan (Filed With SEC on July 2, 2020)
- Amended and Restated Investors Rights Agreement, dated as of August 27, 2019, by and among the registrant and certain of its stockholders (Filed With SEC on June 19, 2020)
- 2015 Equity Incentive Plan (Filed With SEC on June 19, 2020)
- Form of Stock Option Agreement for 2015 Equity Incentive Plan (Filed With SEC on June 19, 2020)
- Employment Offer Letter between the Registrant and Paul Hastings (Filed With SEC on June 19, 2020)
- Employment Offer Letter between the Registrant and Dr. Kanya Rajangam (Filed With SEC on June 19, 2020)
- Employment Offer Letter between the Registrant and Dr. Matthew Plunkett (Filed With SEC on June 19, 2020)
- Exclusive License Agreement between the Registrant, National University of Singapore and St. Jude Research Hospital, Inc (Filed With SEC on June 19, 2020)
- Lease Agreement, dated May 29, 2018, by and between the Registrant and HCP Life Science REIT, Inc (Filed With SEC on June 19, 2020)
- First Amendment to Lease Agreement, dated April 24, 2019, by and between the Registrant and HCP Life Science REIT, Inc (Filed With SEC on June 19, 2020)
- Second Amendment to Lease Agreement, dated May 5, 2020, by and between the Registrant and HCP Life Science REIT, Inc (Filed With SEC on June 19, 2020)
